Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen

Ann Rheum Dis. 2014 Feb;73(2):474-5. doi: 10.1136/annrheumdis-2013-204385. Epub 2013 Sep 3.

Authors

Bruno Tedeschi¹, Laurent Arnaud, Miguel Hie, Alexis Mathian, Zahir Amoura

Affiliation

¹ Department of Internal Medicine, French reference centre for Systemic Lupus Erythematosus, AP-HP, Hôpital Pitié-Salpêtrière, , Paris, France.

PMID: 24001887
DOI: 10.1136/annrheumdis-2013-204385

No abstract available

Keywords: Corticosteroids; Lupus Nephritis; Systemic Lupus Erythematosus; Treatment.

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Cyclophosphamide / therapeutic use
Drug Therapy, Combination
Glucocorticoids / adverse effects*
Humans
Immunosuppressive Agents / therapeutic use*
Lupus Nephritis / drug therapy*
Male
Mycophenolic Acid / analogs & derivatives
Mycophenolic Acid / therapeutic use
Retinal Detachment / chemically induced
Rituximab

Substances

Antibodies, Monoclonal, Murine-Derived
Glucocorticoids
Immunosuppressive Agents
Rituximab
Cyclophosphamide
Mycophenolic Acid